Rivaroxaban Azure 15 mg film-coated tablets Rivaroxaban Azure 20 mg film-coated tablets

Licence status
Authorised: 29/11/2024
Active substances
Rivaroxaban, Rivaroxaban
Dosage Form
Film-coated tablet
Licence number
PA22871/028/005
Licence holder
Azure Pharmaceuticals Ltd.

Product documents

Licence information

ATC code
B01AF01 rivaroxaban
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
29/11/2024

Interchangeable information